每经AI快讯，有投资者在投资者互动平台提问：贵公司有电子氟化液的产品布局吗？另外，高纯氢氟 酸的产值是多少？谢谢 （文章来源：每日经济新闻） 多氟多（002407.SZ）8月29日在投资者互动平台表示，公司目前没有问题所述的氟化液产品；2025年上 半年公司电子信息材料实现营收2.4亿元。 ...

Core Viewpoint - The company reported a decline in revenue and net profit for the first half of 2025, attributing the decrease to intense industry competition and low market prices despite an increase in the production and sales volume of some key products [1][2]. Group 1: Financial Performance - In the first half of 2025, the company achieved a revenue of 4.328 billion yuan, a year-on-year decrease of 6.65% [1] - The net profit attributable to shareholders was 51 million yuan, down 16.55% year-on-year [1] - Basic earnings per share were 0.04 yuan [1] Group 2: Business Segments and Contributions - Revenue contributions from various segments: Fluorine-based new materials accounted for 30.39%, electronic information materials 5.55%, new energy materials 34.97%, and new energy batteries 25.30% [2] - Gross profit contributions from these segments were 8.62%, 19.53%, and 9.74% respectively [2] Group 3: Product Performance and Strategies - The shipment volume of lithium hexafluorophosphate in the first half was approximately 23,000 to 24,000 tons, with an expected annual shipment of around 50,000 tons [2] - The gross margin for lithium hexafluorophosphate fluctuated between 15% and 20% due to price volatility driven by raw material costs [2] - The company employs a mixed procurement strategy for lithium carbonate, adjusting inventory based on market price dynamics [2] Group 4: Future Outlook and Developments - The battery segment shipped around 3.2 GWh in the first half, with expectations for an increase in the second half [2] - The company is focusing on solid-state battery development in collaboration with top domestic universities and research institutions, currently optimizing material performance and cost [2] - The company plans to expand its production capacity for boron isotope products, which currently contribute minimally to profits but are expected to drive growth as capacity increases [2] - The electronic information materials segment is facing challenges due to a downturn in the photovoltaic industry, but the company aims to expand its client base in the semiconductor and chip sectors [2]

Business Overview - Kangda New Materials is a leading fine chemical enterprise in China, specializing in high-end adhesives and polymer new materials, with over 30 years of technological accumulation and innovation [2]. - The company maintains the largest market share in the domestic market for wind turbine blade structural adhesives [2][3]. Wind Power Sector Performance - In 2024, the sales volume of wind turbine blade epoxy structural adhesives exceeded 40,000 tons, while epoxy infusion resin sales reached 45,000 tons, showing steady growth over three consecutive years [3]. - In Q1 2025, the company continued to lead the industry in sales of wind turbine blade epoxy structural adhesives [3]. Core Competitiveness - The company has nearly 300 authorized patents and several industry standards, supported by a national enterprise technology center [4]. - It has established a strong customer base and received multiple industry honors and certifications, ensuring product quality recognition [4]. Financial Performance - In Q1 2025, the net profit attributable to shareholders reached 6.3718 million yuan, a 125.70% increase compared to the same period last year, driven by significant revenue growth and improved operational efficiency [5]. Acquisition Strategy - The company intends to acquire Chengdu Zhongke Huamei Electronics Co., Ltd., a high-tech enterprise specializing in integrated circuit products, to expand into the semiconductor integrated circuit field [6][7]. - This acquisition aims to enhance profitability and operational sustainability by integrating quality assets in the special integrated circuit design and testing sectors [7]. R&D and Product Development - The company is developing aluminum oxide targets and CMP (Chemical Mechanical Polishing) slurries for semiconductor manufacturing, with ongoing internal testing [7]. - Its subsidiary, Dalian Qihua, specializes in high-quality epoxy resin production, serving various industries including new energy and aerospace [7]. International Expansion - The establishment of a new adhesive materials production base in Thailand aims to meet overseas customer demands and enhance international business operations [8]. - The company is actively expanding its overseas market presence, particularly in Southeast Asia, Central Asia, and South Asia, leveraging its core product advantages [8].

Investment Rating - The report maintains a "Buy" rating for the company, indicating an expectation that the company's stock will outperform the benchmark index by more than 20% over the next 6-12 months [2][6]. Core Views - The company has faced challenges in its zeolite and pharmaceutical segments due to weak downstream demand, but there is optimism regarding the growth potential from its various new material developments [4][9]. - The financial performance for 2024 shows a total revenue of RMB 3.693 billion, a decrease of 14.22% year-on-year, and a net profit attributable to shareholders of RMB 246 million, down 67.72% year-on-year [4][10]. - The report highlights the company's ongoing research and development efforts and the successful progress in new materials, which are expected to drive long-term growth [9][12]. Financial Summary - For 2024, the company reported total revenue of RMB 36.93 billion, with a significant decline in net profit to RMB 2.46 billion, reflecting a 67.72% decrease compared to the previous year [4][10]. - The first quarter of 2025 saw a revenue drop of 8.17% to RMB 861.23 million, with a net profit decrease of 18.76% to RMB 79.87 million [12]. - The earnings per share (EPS) estimates for 2025, 2026, and 2027 are projected to be RMB 0.39, RMB 0.48, and RMB 0.56 respectively, with corresponding price-to-earnings (PE) ratios of 28.4, 23.1, and 19.6 [6][8]. Business Segment Performance - The functional materials segment generated RMB 30.19 billion in revenue for 2024, down 10.30% year-on-year, with a gross margin of 39.96% [9]. - The company has maintained its leading position in high-end liquid crystal monomer materials and has seen good development in OLED materials, while also making progress in semiconductor manufacturing materials [9][12]. - The life sciences and pharmaceutical business experienced a revenue decline of 28.65% to RMB 6.29 billion in 2024, although the gross margin improved to 38.16% [9]. Future Outlook - The company is expected to expand its production capacity in functional materials, with the first phase of the Penglai project set to gradually come online in the first half of 2025 [9]. - The report emphasizes the potential for growth in various new materials, including applications in the petrochemical sector and advancements in OLED and semiconductor materials [9][12].